Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients
Bausch Health Americas, Inc.
Sleep disturbance is perhaps one of the most prevalent complaints of patients with
long-standing painful conditions. Nabilone is a medication that is approved by Health Canada
as an anti-emetic (prevent vomiting) for patients undergoing chemotherapy. Nabilone, due to
its sleep promoting properties, is sometimes prescribed by physicians to pain patients to
help improve their sleep. However, there is no direct research evidence to either support or
refute this practice. This study will investigate if nabilone is effective in improving sleep
in insomnia and pain patients.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.